Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Intelligent Bio Solutions (INBS) EBITDA Margin (2020 - 2024)

Historic EBITDA Margin for Intelligent Bio Solutions (INBS) over the last 5 years, with Q1 2024 value amounting to 380.04%.

  • Intelligent Bio Solutions' EBITDA Margin rose 10267400.0% to 380.04% in Q1 2024 from the same period last year, while for Mar 2024 it was 356.89%, marking a year-over-year increase of 674700.0%. This contributed to the annual value of 831.58% for FY2023, which is 2906800.0% down from last year.
  • According to the latest figures from Q1 2024, Intelligent Bio Solutions' EBITDA Margin is 380.04%, which was up 10267400.0% from 248.83% recorded in Q4 2023.
  • Over the past 5 years, Intelligent Bio Solutions' EBITDA Margin peaked at 18.36% during Q4 2022, and registered a low of 9929.13% during Q1 2021.
  • Over the past 5 years, Intelligent Bio Solutions' median EBITDA Margin value was 380.04% (recorded in 2024), while the average stood at 1454.22%.
  • Its EBITDA Margin has fluctuated over the past 5 years, first soared by 92323300bps in 2022, then tumbled by -7099800bps in 2023.
  • Intelligent Bio Solutions' EBITDA Margin (Quarter) stood at 2034.18% in 2020, then surged by 90bps to 205.49% in 2021, then soared by 91bps to 18.36% in 2022, then tumbled by -1256bps to 248.83% in 2023, then plummeted by -53bps to 380.04% in 2024.
  • Its EBITDA Margin stands at 380.04% for Q1 2024, versus 248.83% for Q4 2023 and 307.81% for Q3 2023.